Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye
Status:
COMPLETED
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The clinical investigation was intended to investigate the efficacy, ocular tolerability and safety of Vizol S Lipid Balance, a new eye drops, emulsion developed by JADRAN - GALENSKI LABORATORIJ d.d., in patients with moderate to severe evaporative DED after a treatment for 30 days.